CLEC3B as a Prognostic and Immunological Biomarker in Pan-Cancer: Multi-Omics Profiling and Validation in Pancreatic Cancer and Exosomes
Kai Nan,1,* Lei Zhang,2,* Yulong Peng,3 Jing Huang,3 Su Yin,3 Yujia Zou,4 Kaikai He,4 Ming Zhang5 1Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China; 2Department of Pharmacy, Shaanxi Provincial Hospita...
Saved in:
| Main Authors: | Nan K, Zhang L, Peng Y, Huang J, Yin S, Zou Y, He K, Zhang M |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-05-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clec3b-as-a-prognostic-and-immunological-biomarker-in-pan-cancer-multi-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-cancer analysis identifies CLEC12A as a potential biomarker and therapeutic target for lung adenocarcinoma
by: Desheng Zhou, et al.
Published: (2025-04-01) -
Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma
by: Shuntaro Tsukamoto, et al.
Published: (2025-05-01) -
A pan-cancer study of ADAM9’s immunological function and prognostic value particularly in liver cancer
by: Mandana AmeliMojarad, et al.
Published: (2024-11-01) -
ITGAV as a promising diagnostic, immunological, and prognostic biomarker in pan-cancer
by: Hanyang Su, et al.
Published: (2025-08-01) -
Prognostic value and immunological role
of PTPN21 in pan-cancer analysis
by: Yane Yang, et al.
Published: (2023-07-01)